Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)
Crossref DOI link: https://doi.org/10.1007/s10096-014-2113-z
Published Online: 2014-05-18
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cunha, B. A.
Text and Data Mining valid from 2014-05-18
